乙型肝炎表面抗原基因DNA介导的体液免疫初步研究

用ＣＰＲ技术从纯化的乙型肝炎病毒核酸中扩增出ｐｅｒＳ２－Ｓ基因,并将其定向克隆于真核表达质粒ｐｃＤＮＡ３．１（＋）中,构建成带有完整的乙肝表面前Ｓ２抗原基因和Ｓ基因的重组质粒。重组质粒经酶切及部分序列分析鉴定后,瞬时转梁小鼠Ｌ细胞,ＥＬＩＳＡ法检测到培养上清液有ＨＢｓＡｇ表达。用纯化的重组质粒静脉、肌肉和皮下注射免疫ＢＡＬＢ／ｃ小鼠,首次接种质粒ＤＮＡ３周后,血清抗体开始出现,再次加强２周后,阳性     

肝片吸虫保护性抗原基因在卡介苗中的表达

用ECoR　I酶切合肝片吸虫保护性抗原基因FH3的重组质粒pUC18／FH3，回收FH3(约1．0kb)片段并测定其碱基序列．FH3片段以正确相位插入到E．coli—分枝杆菌穿梭表达质粒载体pMV261中，构建含有肝片吸虫保护性抗原基因的重组穿梭质粒．通过电转移法转化卡介苗，斑点杂交实验汪明，重组卡介苗中含有此抗原基因．热诱导FH3基因在卡介苗中的表达，并对基图表达产物进行别SDS—PAGE分析．结果显示，表达产物相对分子量为22kD．     

肝片吸虫抗原基因的克隆与筛选

提取肝片吸虫总RNA,经oligo(dT)-纤维素柱分离得到mRNA,反转录合成cDNA后,连接Eco RI人工合成接头,酶切后克隆到表达型质粒载体pGEX-1λT,转化大肠杆菌JM107菌株构建肝片吸虫cDNA文库(文库大小约为2.1×105)．用免疫印迹筛选出5个阳性克隆,分别命名为pFH2,pFH4,pFH16,pFH21和pFH29．其中pFH21印迹信号最强．Eco RI酶切pFH21显示插入片段大小约为1.0kb.重组子pFH21经SDS-PAGE电泳显示表达有一个重组蛋白,分子量约为48kD.     

重组质粒βhCG—pPIC9K的构建及嗜甲醇酵？…

目的：为用基因重组技术表达ｈＣＧ避孕疫苗抗原,构建在酵母细胞中表达的重组质粒βｈＣＧ－ｐＰＩＣ９Ｋ,转化嗜甲醇酵母,方法：根据βｈＣＧ的ｃＤＮＡ序列设计两条引物,使上游带ＥｃｏＲⅠ酶切位点,下游带ＮｏｔⅠ酶切位点,以质粒βｈＣＧ－ＰＢＳＫＳ为模板,进行ＰＣＲ扩增反应;将所得的ＤＮＡ片段经ＥｃｏＲⅠ和ＮｏｔⅠ双酶切后用Ｔ４连接酶与ｐＰＩＣ９Ｋ质粒进行连接,然后导入大肠杆菌ＤＨ５α,用ＰＣＲ筛选阳性克     

牦牛肝片吸虫四种抗原交叉免疫印迹分析

用牦牛肝片吸虫四种抗原分别制备四种抗血清，其ＥＳＩＳＡ效价 １：８００，１：１６００，１：３２００和１：８００．ＳＤＳ－ＰＡＧＥ电泳区带组分分别为２５，２４，１８和９条带；免疫印迹结果，各种抗清与相庆抗原作用的主要抗原成份分别为５，１０，７和３；四种抗原中存在的共同抗原为１７．２ｋＤ；特征抗原ＨＡ为２９．９ｋＤ，ＳＡ为２７．２ｋＤ的２４．３ｋＤ；正常兔血清与各个抗原间均未出现免疫反应。     

红细胞生成素单克隆抗体制备及初步鉴定

为获取高效价的红细胞生成素（ＥＰ）单抗,以建立重组人红细胞生成素（ｈＥＰＯ）测定方法。用基因重组ｈＥＰＯ与小鼠血清白蛋白经Ｎ－羟基琥珀酰亚胺基－３（２－吡啶基二硫）丙酸酯胞;用间接ＥＬＩＳＡ和免疫印迹技术将ｈＥＰＯＭｃＡｂ与白色念珠菌胞质抗原的ＭｃＡｂ,嗜肺性军团病杆菌ＭｃＡｂ,ＨＣＶ核心肽ＭｃＡｂ,人μ链ＭｃＡｂ,ＩＦＮ－γＭｃＡｂ的间接ＥＬＩＳＡ同时进行特异性鉴定。经融合后检测获取一株分泌ｈＥ     

红细胞生成素单克隆抗体制备及初步鉴定

为获取高效价的红细胞生成素（ＥＰＯ）单抗,以建立重组人红细胞生成素（ｈＥＰＯ）测定方法。用基因重组的ｈＥＰＯ与小鼠血清白蛋白经Ｎ－羟基琥珀酰亚胺基－３（２－吡啶基二硫）丙酸酯（ＳＰＤＰ）交联后,常规免疫ＢＡＬＢ／ｃ小鼠,并用细胞融合技术制备分泌ｈＥＰＯＭｃＡｂ杂交瘤细胞;用间接ＥＬＩＳＡ和免疫印迹技术将ｈＥＰＯＭｃＡｂ与白色念珠菌胞质抗原的ＭｃＡｂ、嗜肺性军团病杆菌ＭｃＡｂ、ＨＣＶ核心肽ＭｃＡｂ、人μ链ＭｃＡｂ、ＩＦＮ－γＭｃＡｂ的间接ＥＬＩＳＡ同时进行特异性鉴定。经融合后检测,获取一株分泌ｈＥＰＯＭｃＡｂ的杂交瘤细胞系。初步鉴定,ｈＥＰＯＭｃＡｂ针对ｈＥＰＯ间接ＥＬＩＳＡ效价为１０－７（对照腹水为１０－３）;免疫印迹结果显示：此ＭｃＡｂ与基因重组的ｈＥＰＯ在分子量３０００～４０００之间有一条显色带,而其它几种ＭｃＡｂ均为阴性结果。小分子物质经与同种动物（免疫用动物）血清白蛋白交联后用作免疫抗原,可提高小分子物质的免疫原性,容易获取高效价的单克隆抗体。     

黄芪多糖对荷瘤小鼠红细胞免疫功能的影响

采用红细胞Ｃ３ｂ受体花环率（ＲＢＣ－Ｃ３ｂＲＲ），红细胞免疫复合物花环率（ＲＢＣ－ＩＣＲＲ），血清中红细胞Ｃ３ｂ受体花环抑制率（ＲＥＩＲ）和红细胞Ｃ３ｂ受体花环促进率（ＲＦＦＲ）等四个指标，研究了黄芪多糖对Ｓ１８０Ａ小鼠肝癌（ＨＥＰＡ）和小鼠红细胞免疫功能的影响。结果表明，黄芪多糖能明显提高荷瘤小鼠的ＢＢＣ－Ｃ３ｂＲＲ和ＲＦＥＲ，降低ＲＢＣ－ＩＣＲＲ和ＲＦＩＲ。这一结果说明黄芪多糖对荷瘤小鼠红细胞免疫有明显的促进作用。     

抗牛免疫缺陷病毒（BIV）穿膜蛋白gp45杂交瘤细胞株的建立

编码牛免疫缺陷病毒（ＢＩＶ）穿膜蛋白的一个４００ｂｐ的基因片断被克隆到ｐＡＴＨ表达载体上，此 重组的融合蛋白ＴｒｐＥ－Ｅｎｖ８在大肠杆菌中得到高效表达，而且包含有与ＢＩＶ抗体特异性反应的抗原决定簇。我们用此融合蛋白免疫ｂａｌｂ／ｃ小鼠得到与ＢＩＶ穿膜蛋白特异性反应的杂交瘤。此单克隆抗体在蛋白印迹法分析中与重组的ＴｒｐＥ－Ｅｎｖ８有特异性反应，用免疫酶染色法可检测ＢＩＶ在体外的复制。     

肝片吸虫抗原基因转基因苜蓿再生的研究

用直接转化法，将构建有肝片吸虫保护性抗原基因FH3的植物表达载体pBI121-FH3,导入感受态的根瘤农杆菌EHA105；以重组的根瘤农杆菌为介导，用叶盘法转化苜蓿外植体，筛选得到抗Kan转化外植体；抗性外植体通过诱导丛生芽和诱导生根，再生出完整植株，提出植株总DNA进行Southern blot，结果表明，FH3基因已经整合入苜蓿基因组中。     

几种寄生虫抗原组分的SDS-PAGE电泳比较分析

通过提取制备猪带绦虫、猪囊尾蚴虫体、猪囊虫囊液、多房型束球绦虫、肝片吸虫、细颈囊尾蚴、细颈囊尾蚴囊液和羊绦虫等8种寄生虫抗原，运用SDS－PAGE电泳法比较各种抗原的蛋白质的组成，不连续SDS－PAGE电泳结果显示猪带绦虫、猪囊尾蚴虫体、猪囊虫囊液、多房示绦虫、肝片吸虫、细颈囊尾蚴、细颈囊尾蚴囊液和羊绦虫等几种抗原的蛋白质在凝胶中分别有31，23，18，17，21，22，8和24条带，分子量在13kD-134kD之间，8种抗原的电泳带之间既有相似性又有特异性，其抗原的共同蛋白质亚基带的分子量为63kD,38kD和24kD。     

乙肝病毒核酸疫苗诱导小鼠细胞免疫应答的研究

研究利用核酸疫苗诱生乙型肝炎病毒 (HBV)表面抗原 (S)细胞免疫应答的作用 .免疫前于BALB/C小鼠股四头肌注射 75 %盐酸布比卡因 ,三天后同样部位注射包含HBsAg基因片段的重组质粒pcDNAHBs .采用3H -TdR掺入法测定免疫小鼠脾细胞增殖能力 ;XTT法测定其脾细胞分泌IL 2活性 .结果表明注射乙肝核酸疫苗可以使小鼠脾细胞增殖 ,小鼠脾细胞分泌上清中可检测到IL - 2活性     

MT—hGH基因注入小鼠受精卵的研究

用显微注射法，将MT－hGH融合基因注入昆明白小鼠受精卵雄原核中，受注的原核卵经体外培养发育的198枚2细胞胚、45枚桑椹胚和161枚胚泡，移植到54只假孕受体，其中16只妊娠产仔只，存活到供试的仔鼠25只，小鼠长到3个月后，切尾制备DNA，经DNA斑点杂交和Southern印迹杂交检测基因整合情况，25只小鼠中3只有融合基因整合，称为转基因小鼠，仔鼠21日龄离乳后饮水中加入锌（Za^ )，以诱导融合基因表达，85日龄时，转基因小鼠体重比对照组重32．0％，还讨论了基因整合方式对胚胎发育的影响。     

DNA疫苗经基因枪介导的免疫研究

将基因枪介导的DNA疫苗用于小鼠腹部免疫,并用免疫组化法检测gD抗原在接种部位的表达,利用ELISA检测血清中的抗gD抗体,并采用病毒攻击检测DNA疫苗对动物的保护效果。结果表明,基因枪可有效地将DNA质粒运送至小鼠皮肤组织,DNA疫苗携带的抗原保护基因gD2糖蛋白能在真皮和肌肉组织中高效表达。同时,免疫小鼠体内产生高滴度的中和抗体,能有效抵抗HSV2病毒的攻击。     

Effect of HS2 and HS3 elements on erythroid-specific expression in transgenic mice

The expression plasmids CMV/GFP, HS2ALL, HS3ALL and HS23ALL were selected to investigate the effect of HS2 and HS3 element on erythroid-specific expression in transgenic mice. These plasmids were digested with restriction enzymes and purified. And five DNA fragments, CMV/GFP, HS2/GFP, CMV/HS2/GFP, HS23/GFP and HS3/GFP were obtained. After purification, the above DNA fragments were microinjected into the pre-nuclei of the mice fertilized eggs and transgenic mice were generated, with an integration rate of 10.89%. The green fluorescence protein(GFP) expression in many transgenic mouse tissues was determined by FACS analysis. The results showed that the HS2 and 1.7 kb of β-globin gene promoter were sufficient for the erythroid-specific expression of β-globin gene. The GFP expression of different recombinant constructs was also analyzed in blood of all the transgenic mice with FACS. The results indicated that HS2 and HS3 had the same enhancement activity on the regulation of β-globin gene expression. Moreover, these two elements showed a significant synergistic effect on gene expression at the transgenic mouse level, although the GFP expression varied largely among different transgenic mouse litters.     

HIV-1C亚型DNA疫苗诱导小鼠免疫反应的研究

 构建含中国流行株HIV-1 C亚型核心蛋白gag基因的重组质粒pVAX-gag,并在体外进行了表达与鉴定.同时构建了含此gag基因的原核表达质粒pGEX-gag,表达纯化并鉴定重组蛋白Gag.以质粒pVAX-gag免疫Balb/C小鼠后,用ELISpot和流式细胞仪检测其细胞免疫反应.再以纯化后的重组蛋白Gag作为包被抗原,用ELISA检测其体液免疫反应.结果显示重组质粒pVAX-gag免疫小鼠后可有效地诱导机体产生细胞免疫和体液免疫反应,且免疫剂量和免疫效果存在一定的正相关性.重组原核表达质粒pGEX-gag的表达产物能与抗p24单克隆抗体发生特异性反应,可用于抗HIV抗体检测.     

猪带绦虫抗原基因TS76真核表达的研究

将猪囊尾蚴抗原基因TS76亚克隆至VR1020真核表达载体中，用菌浇原位杂交法筛选重组质粒，将其转染Cos7细胞，用Northern Blot鉴定插入片段的mRNA转录，用ELISA检测其表达产物。结果表现：VTS76在真核细胞中能够转录TS76基因；表面产物被兔抗猪囊尾蚴高免血清所识别，在转染真核细胞后24h，即可检测到正确表达的猪囊尾蚴抗原蛋白。     

GAGE-1 DNA肿瘤疫苗的构建及其抗肿瘤治疗效果的试验研究

目的 观察G antigen 1 (GAGE-1)核酸疫苗pcDNA3.1+/GAGE-1免疫小鼠后,对表达GAGE-1抗原的B-16/GAGE-1肿瘤细胞的保护作用.方法 将C57 BL/6小鼠随机分为4组,与0、2、4周分别接种pcDNA3.1＋/GAGE-1（实验组1）、pcDNA3.1＋/GAGE-1/白介素2（实验组2）、pcDNA3.1＋（对照组1）,pcDNA3.1＋/白介素2（对照组2）各三次.末次免疫后10d小鼠用于肿瘤细胞攻击试验：分别于左背部、右背部皮下种植B16肿瘤细胞、B16/GAGE-1肿瘤细胞.种植肿瘤细胞（荷瘤）后观察成瘤时间、肿瘤大小和荷瘤后小鼠的生存时间及生存率. 结果： pcDNA3.1+/GAGE-1/IL-2质粒免疫的小鼠在种植B16/GAGE-1、B16/pcDNA3.1+后,发现小鼠成瘤时间明显延迟,成瘤减小,生存期明显延长.结论:pcDNA3.1+/GAGE-1/IL-2 DNA 疫苗在体内能诱导出显著的GAGE-1特异性肿瘤免疫应答,且能抑制体内已经存在的少量肿瘤细胞的成瘤     

Specific anti-tumor effect induced by attenuated Salmonella typhimurium vaccine expressing extracellular region of vascular endothelial growth factor receptor 2

The purposes of this research were to study the stable expression of exogenous gene encoding therapeutic protein in attenuated Salmonella typhimurium, observe the metabolism of oral gene vaccine carried by attenuated Salmonella typhimurium in BALB/c mouse, and investigate the feasibility of prevention and treatment of tumors by the recombinant bacteria. Recombinant plasmid pcDNA3.1 VEGFR2(n1-7) was transformed into competent attenuated Salmonella typhimurium SL3261 to develop oral DNA vaccine SL3261-pcDNA3.1 VEGFR2(n1-7). To observe whether the exogenous gene can be expressed in the recombinant bacteria, PCR was performed to amplify the CMV promoter of the eukaryotic expression vector as the proof of stable expression of exogenous protein; transmission elec- tron microscopy (TEM) was applied to observe the morphology of the recombinant bacteria to confirm that the exogenous gene has no impact on the growth of the bacteria, and then BALB/c mice were immunized with the gene vaccine. After inoculation of the gene vaccine, the recombinant bacteria SL3261 could be detected in the tissues such as small intestine, colon, liver and spleen. And then, mice in each group were challenged with tumor cells. The results of animal experiment showed that tumor growth of the mice in experimental group was inhibited and survival time of immunized mice was prolonged compared with control groups. A higher lymphocyte infiltration in tumors from animals treated with DNA vaccine was observed. Immunohistochemical analysis of tumor samples revealed an en- hanced accumulation of CD8 cytotoxic T lymphocytes, as well as an increase in CD4 cells in the tumors of animals treated with the oral gene vaccine compared to tumors from control group mice. Ultrastructure of the tumor tissue showed that tumor cells in the samples of the immunized mice were well-differentiated. Our research confirmed that the exogenous gene can be stably expressed in the attenuated Salmonella typhimurium and has no impact on the growth of the recombinant bacteria; the exogenous gene can de delivered to the host by attenuated Salmonella typhimurium to produce anti-tumor effect with no obvious cytotoxity to the host. In this study, it is established that attenuated Salmonella typhimurium could be used as a vector for oral gene vaccine, and our study provided a theoretical basis for the body distribution and the metabolism of the recombinant bacteria. This strategy may provide a simple, safe and effective way for the prevention and treatment of tumors.